





































Enhanced Diagnostic Capability for Glaucoma of
3-Dimensional Versus 2-Dimensional Neuroretinal
Rim Parameters Using Spectral Domain Optical
Coherence Tomography
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Purpose: To compare the diagnostic capability of 3-dimensional
(3D) neuroretinal rim parameters with existing 2-dimensional (2D)
neuroretinal and retinal nerve fiber layer (RNFL) thickness rim
parameters using spectral domain optical coherence tomography
(SD-OCT) volume scans.
Materials and Methods: Design: Institutional prospective pilot
study. Study population: 65 subjects (35 open-angle glaucoma
patients, 30 normal patients). Observation procedures: One eye of
each subject was included. SD-OCT was used to obtain 2D RNFL
thickness values and 5 neuroretinal rim parameters [ie, 3D mini-
mum distance band (MDB) thickness, 3D Bruch’s membrane
opening-minimum rim width (BMO-MRW), 3D rim volume, 2D
rim area, and 2D rim thickness]. Main outcome measures: Area
under the receiver operating characteristic curve values, sensitivity,
and specificity.
Results: Comparing all 3D with all 2D parameters, 3D rim
parameters (MDB, BMO-MRW, rim volume) generally had higher
area under the receiver operating characteristic curve values (range,
0.770 to 0.946) compared with 2D parameters (RNFL thickness,
rim area, rim thickness; range, 0.678 to 0.911). For global region
analyses, all 3D rim parameters (BMO-MRW, rim volume, MDB)
were equal to or better than 2D parameters (RNFL thickness, rim
area, rim thickness; P-values from 0.023 to 1.0). Among the three
3D rim parameters (MDB, BMO-MRW, and rim volume), there
were no significant differences in diagnostic capability (false dis-
covery rate >0.05 at 95% specificity).
Conclusions: 3D neuroretinal rim parameters (MDB, BMO-MRW,
and rim volume) demonstrated better diagnostic capability for
primary and secondary open-angle glaucomas compared with 2D
neuroretinal parameters (rim area, rim thickness). Compared with
2D RNFL thickness, 3D neuroretinal rim parameters have the
same or better diagnostic capability.
Key Words: primary open-angle glaucoma, spectral domain optical
coherence tomography, 3-dimensional volume scan, minimum
distance band, Bruch’s membrane opening-minimum rim width
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Glaucoma is the leading cause of irreversible blindness inthe world, currently affecting over 62.2 million people
globally and over 3.3 million in North America.1 Spectral
domain optical coherence tomography (SD-OCT) has
replaced time domain optical coherence tomography as the
most widely used quantitative structural assessment of the
optic nerve head (ONH) and the surrounding retinal nerve
fiber layer (RNFL) for glaucoma.2 These structural
parameters remain essential in evaluating glaucoma since
structural changes such as RNFL thinning often precede
visual field deficits.3,4 However, despite the advent of the
newer 3-dimensional (3D) technical capabilities of SD-
OCT, commensurate 3D software development has lagged
behind; and current commercially available SD-OCT 3D
software for glaucoma care needs further development.
Perhaps the most common SD-OCT imaging scan in
glaucoma is the 2-dimensional (2D) peripapillary RNFL
circle scan centered on the ONH. This methodology has
some inherent diagnostic limitations due to ONH anatomic
variability, myopia, glaucomatous RNFL reflectivity loss,
peripapillary atrophy (PPA), and other issues.5–15 For
ONH evaluation, assessment has classically been quantified
by the cup-to-disc ratio (CDR), and OCT can assess CDR
by using a reference plane 150 mm above the retinal pig-
mented epithelium (RPE)/Bruch’s membrane (BM) com-
plex. However, these assessments are often unreliable due
to variability of cup anatomy.2,16 Furthermore, CDR
assessment by OCT scanning reports can be B0.1 higher
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than that determined clinically by glaucoma specialists.17 In
terms of future directions for OCT structural evaluation,
studies have shown that 3D imaging parameters can dem-
onstrate at least the same diagnostic capabilities as 2D
RNFL thickness, can improve diagnostic sensitivity of
glaucoma at 95% specificity, can track glaucomatous
changes of acute intraocular pressure (IOP) elevation in
nonhuman primate models, and can longitudinally evaluate
structural changes secondary to glaucoma.18–23 Therefore,
there is clearly a need to develop and test 3D SD-OCT
methods for interpreting glaucomatous neuroretinal rim
changes,24 because 3D algorithms may hold better potential
than 2D methods for detecting subtle structural changes in
the clinic.
Given the diagnostic potential of 3D imaging from
past studies,18–20,22–27 this study investigated 5 neuroretinal
rim parameters to determine the best method of analyzing
3D volume data. This study specifically features two newer
3D neuroretinal rim parameters: the Bruch’s Membrane
Opening-Minimum Rim Width (BMO-MRW) and the
“minimum distance band” (MDB) thickness. Using an SD-
OCT radial scan protocol, past studies have defined the
BMO-MRW as the neuroretinal rim bound by the shortest
distance from BMO to the cup surface19,20 and have dem-
onstrated a stronger structure-function relationship in
glaucomatous eyes with the BMO-MRW compared with
RNFL thickness and other 2D parameters.28 Using an SD-
OCT raster volume scan protocol, our group has previously
reported the MDB neuroretinal thickness parameter, which
is a circular band that is bound by the shortest distance
between the termination of the RPE/BM complex and the
closest corresponding points along the cup surface.2,29
Under this same SD-OCT raster volume scan protocol, we
were also able to examine older 150 mm reference plane
based neuroretinal rim tissue parameters including rim
area, rim volume, and rim thickness. We hypothesize that
newer 3D neuroretinal rim parameters (eg, MDB and
BMO-MRW) are better at diagnosing glaucoma than the
classic 2D parameters used today and that different SD-
OCT scanning methods can offer new and additional
parameters for ONH evaluation. Therefore, in this study,
we evaluated the diagnostic capabilities of 3D and 2D
neuroretinal parameters as well as 2D RNFL thickness
from SD-OCT imaging in a group of primary and secon-
dary open-angle glaucoma and normal patients who were




All study subjects were recruited from the Glaucoma
Service at the Massachusetts Eye and Ear Infirmary
between September 2014 and June 2015 as part of a study
approved by the Massachusetts Eye and Ear Infirmary
Institutional Review Board. All included patients provided
informed consent in accordance with the Declaration of
Helsinki for research involving human subjects as well as
the Health Insurance Portability and Accountability Act
Regulations. A glaucoma specialist (T.C.C.) examined all
patients. Each patient’s clinic visit documentation included
history of present illness, best-corrected visual acuity,
refraction, slit-lamp examination, Goldmann applanation
tonometry, gonioscopy, and dilated ophthalmoscopy. All
imaging and diagnostic procedures were performed for all
patients on the same day and included Spectralis OCT
imaging, stereo disc photography (Visucam Pro NM; Carl
Zeiss Meditec Inc.), and Humphrey visual field (HVF)
testing (Swedish Interactive Threshold Algorithm 24-2 test
of the Humphrey visual field analyzer 750i; Carl Zeiss
Meditec Inc.). Only 1 eye per patient was included in the
study.
All patients were dilated for imaging (HRA/Spectralis
software version 5.4.8.0). We performed 3 imaging proto-
cols on each subject on the same day including: (1) circle
scan for RNFL thickness; (2) 2020-degree raster volume
scan of the ONH for MDB thickness, rim volume, rim area,
and rim thickness measurements; (3) radial scan of the
ONH for BMO-MRW measurements, with manual cor-
rection of the BMO border in the clinic. Scans were only
included if images: (1) had a signal strength Z15 (range, 0
to 40)30; (2) had clear visibility of the fundus, optic disc, and
RNFL; and (3) were continuous without significant blank
areas. The automatic real-time eye-tracking system of the
Spectralis OCT allowed for averaging of multiple scans at
the same location.
From the 3 imaging protocols, we were able to
investigate 6 diagnostic parameters: 2D RNFL thickness,
2D neuroretinal rim area, 2D neuroretinal rim thickness,
3D neuroretinal rim volume, 3D MDB thickness, and 3D
BMO-MRW. RNFL thickness was determined by Hei-
delberg software and was obtained from Heidelberg
Spectralis Exam Reports. The neuroretinal rim parameters
(ie, rim volume, rim area, and rim thickness) and MDB
thickness were calculated from the 3D ONH raster volume
scans with software developed at the Massachusetts Eye
and Ear Infirmary (Figs. 1, 2). This scan protocol con-
sisted of 193 raster images over a region B6mm6mm.
The RPE/BM complex (Fig. 1A, pink dotted circle) and
the cup surface (Fig. 1B, yellow dotted circle) were
reconstructed by segmenting the images. In accordance
with previous definitions of the RPE/BM complex, we
segmented the RPE/BM complex when we were able to
identify either just the RPE, or just the BM, or both the
RPE and BM.31 For rim volume, rim area, and rim
thickness, the traditional reference surface of 150 mm
above the RPE/BM complex was used to calculate the
ONH parameters (Fig. 1C with 150 mm reference plane
represented by yellow letter Z).16,32 Rim volume was cal-
culated by measuring the tissue bounded below by the
150 mm reference surface, above by the internal limiting
membrane, and radially by the RPE/BM complex). The
rim area (Fig. 2A) was the projection of the rim volume
(Fig. 2B, C) on a transverse plane. The rim thickness was
the rim volume divided by the rim area. The MDB
thickness was calculated by measuring the shortest dis-
tances from 100 points along the RPE/BM complex to the
cup surface (Fig. 1D) and has been previously described in
detail by our group in recent publications.33,34 The BMO-
MRW thickness was determined from the 24 radial B-scan
protocol, using the Glaucoma Premium Module software
(6.0.11) seen in Figure 3. The BMO-MRW is defined
by the minimum distance between the BM opening and
the internal limiting membrane.19,35 The Glaucoma Pre-
mium Module software is commercially available and
is FDA approved. For each of the 6 parameters, we
measured a total of 9 regions: global, 4 quadrants (infe-
rior, superior, nasal, and temporal), and four 45-degree
sectors (inferonasal, superonasal, inferotemporal, and
superotemporal).
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The inclusion criteria for this study were as follows: (1)
patients who received a dilated eye exam, disc photos, HVF
testing, Spectralis RNFL scan, SD-OCT 3D ONH raster
volume scan, and Spectralis BMO-MRW scans on the same
day; (2) spherical equivalent between 5.0 D to
+5.0 D inclusive; and (3) reliable HVF test results with
r33% fixation losses, r20% false-positive results, and
r20% false-negative results. Patients were excluded from
the study if there was presence of congenital anomalies of
the anterior chamber, corneal scarring or opacities, HVF
loss attributable to a nonglaucoma condition, such as
central retinal vein or artery occlusion or panretinal pho-
tocoagulation, dilated pupillary diameter <2mm, or severe
nonproliferative or proliferative diabetic retinopathy. Only
patients with best-corrected visual acuity of 20/50 or better
were included in this study.
In selecting glaucoma subjects for this study, we
included primary and secondary forms of open-angle
glaucoma. The following types of open-angle glaucoma
were included: primary open-angle glaucoma, normal ten-
sion glaucoma, pseudoexfoliation glaucoma, and pig-
mentary glaucoma. Any patient diagnosed with chronic
angle closure glaucoma, traumatic glaucoma, aphakic
glaucoma, juvenile open-angle glaucoma, or uveitic glau-
coma was excluded from the study. All diagnoses were
confirmed by a glaucoma specialist (T.C.C.). To qualify for
a diagnosis of glaucoma, an abnormal VF was defined by
either 3 or more contiguous pattern SD (PSD) test locations
depressed by 5 dB or more; or 2 or more contiguous PSD
test locations with 1 depressed by 10 dB or more and the
other by 5 dB or more. Abnormal PSD test locations on
the outer rim of the visual field were not considered in the
aforementioned criteria to account for peripheral rim
artifacts.
For normal subjects, patients were included if they
satisfied the following criteria: (1) absence of other ocular
FIGURE 1. Depiction of how neuroretinal rim parameters were derived from the raster volume scan protocol. This example is of a
normal right eye. After volume scans were obtained with Spectralis optic coherence tomography (OCT) imaging (HRA/Spectralis
software version 1.9.1.0, Heidelberg Engineering, Heidelberg, Germany), custom-designed Massachusetts Eye and Ear Infirmary soft-
ware calculated (A and C) rim area, rim volume, and rim thickness and (B and D) minimum distance band (MDB) thickness. A, The pink
dotted circle represents the OCT-based disc border, or retinal pigmented epithelium (RPE)/Bruch’s membrane (BM) complex termi-
nation. B, The yellow dotted circle represents the cup surface points which are closest to the OCT-based RPE/BM complex border, which
defines the outer MDB border (D, pink dotted circle). C, B-scan, where yellow letter Y represents the RPE/BM complex plane, and yellow
letter Z represents the 150 mm reference plane which is 150mm above the RPE/BM complex and which divides the neuroretinal rim
above from the cup below. D, MDB as a 360-degree circumferential blue band, which is bordered above by the cup surface (blue dotted
circle) and below by the OCT-based RPE/BM complex (pink dotted circle).
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disease with the exception of mild cataracts; (2) normal
HVF test results as defined by hemifield test results within
normal limits; and (3) CDR asymmetry r0.2 between eyes.
No patients with physiologic cupping were included, and
CDRs for whites werer0.4 and for African Americans and
Hispanics r0.6.
For patients where both eyes were eligible for inclusion, 1
eye was selected at random using the Microsoft Excel 2010
(Microsoft Corporation, Redmond, WA) random number gen-
erator function “=RANDBETWEEN(min,max).” Defining
“min” as “1,” and “max” as “2,” we assigned the value “1”
to indicate selection of the left eye and “2” to indicate
selection of the right eye.
Statistical Analysis
Results are reported as means±SD, unless otherwise
stated. w2 or 2 sample t tests were used for the comparison
of demographic variables between normal and glaucoma
patients.
For all 9 regions of our 6 parameters (RNFL thick-
ness, MDB thickness, rim area, rim volume, rim thickness,
BMO-MRW), we determined area under the receiver
operating characteristic (AUROC) curve values. To find the
most accurate diagnostic parameter for glaucoma, AUROC
curve values were evaluated with pairwise comparisons, and
false discovery rates were calculated to adjust for the mul-
tiple comparisons. P-values <0.05 were considered stat-
istically significant. All statistical analyses were performed
using SAS 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
There were 65 patients in our study, 35 glaucoma
subjects and 30 normal subjects, with mean age of
67.7±11.0 and 58.5±12.0 years, respectively (P-value
<0.01, Table 1). Statistically significant differences were
also found in clinically assessed CDR as well as HVF mean
and pattern SD (Table 1). Of the glaucoma subjects, 51.4%
(18/35) were categorized as early glaucoma (HVF mean
deviation >6 dB, inclusive) and 48.6% (17/35) as mod-
erate to severe glaucoma (HVF mean deviation worse than
6 dB).
Table 2 shows the AUROC values for all 9 regions for
the 6 parameters investigated in our cohort. Four of the 5
FIGURE 2. Depiction of neuroretinal rim parameters derived from the raster volume scan protocol (ie., neuroretinal rim volume, rim
thickness, and rim area). This example is the normal right eye who had volume scans using Spectralis optical coherence tomography
(OCT) imaging (HRA/Spectralis software version 1.9.1.0, Heidelberg Engineering, Heidelberg, Germany). Using our custom-designed
algorithm, the OCT-based retinal pigmented epithelium (RPE)/Bruch’s membrane (BM) complex border is shown as pink dotted circles
in (A–C) and represents the termination of the RPE/BM complex. A, The integrated reflectance image shows the rim area in yellow. B
and C, Three-dimensional representations of rim volume, which is 150 mm above the OCT-based RPE/BM complex border (pink
dotted circles).
FIGURE 3. Representative integrated reflectance image (A) and associated B-scan (B) of the Bruch’s membrane opening-minimum rim
width (BMO-MRW) scan protocol from Heidelberg Spectralis OCT (HRA/Spectralis software version 1.9.1.0, Heidelberg Engineering
GmbH, Heidelberg, Germany). A, The 24 radial B-scan protocol for measuring the BMO-MRW is shown. The highlighted green line
represents the radial B-scan shown on the right in picture B, BMO-MRW is a measurement of the minimum distance (light blue arrows)
between the internal limiting membrane and BMO.
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top AUROC curve values were for 3D parameters: BMO-
MRW inferotemporal [0.946; 95% confidence interval (CI),
0.89-0.99], BMO-MRW global [0.928 (95% CI, 0.86-0.99)],
BMO-MRW inferior [0.927 (0.86-0.99)], rim volume infer-
otemporal (0.917 [0.85-0.99]), and rim thickness infer-
otemporal (0.911 [0.84-0.99]). As seen in Table 2, global
values of 3D rim parameters (BMO-MRW, rim volume,
and MDB thickness) were equal to or better than 2D
parameters (RNFL thickness, rim area, rim thickness; P-
values ranging from 0.023 to 1.0). In comparisons for
diagnostic ability of the 3D rim parameters as determined
by AUROC values using false discovery rates, no statisti-
cally significant differences were detected. When pairwise
comparisons were done between 3D and 2D parameters for
global and quadrant regions, we found that 3D parameters
were similar to 2D parameters, except for the following
pairs: 3D BMO-MRW better than 2D RNFL (nasal
P=0.035, temporal P=0.037), 3D BMO-MRW better
than 2D rim area (global P=0.023, inferior P=0.009, and
temporal P=0.036), 3D BMO-MRW better than 2D rim
thickness (superior P=0.014, nasal P=0.031, and tem-
poral P=0.036), and 3D rim volume better than 2D rim
area (inferior P=0.018).
Figures 4 and 5 depict the AUROC graphs for visual
comparison between RNFL, BMO-MRW, MDB, and
RNFL thickness, demonstrating that at B95% specificity,
BMO-MRW, MDB thickness, rim volume, and RNFL
thickness yielded sensitivity values of 86%, 83%, 68%, and
60%, respectively. Fig. 5 shows the AUROC curves for
MDB thickness, BMO-MRW, rim volume, and RNFL for
the 4 quadrants and 4 sectors. In Fig. 5, there is a trend for
RNFL thickness having lower total AUROC curves as
compared with all three 3D neuroretinal rim parameters (ie,
MDB thickness, BMO-MRW, and rim volume).
DISCUSSION
Our study demonstrates that 3D neuroretinal rim
parameters obtained by SD-OCT imaging may be superior
to 2D SD-OCT diagnostic tools in differentiating glaucoma
from normal patients. Similar to patterns established in
previous studies,36,37 we also found that the inferior quad-
rant and inferotemporal sector more consistently exhibited
higher diagnostic capabilities compared with other regions
for all 6 measured parameters (Table 2).9,22,38–41 Using
AUROC curves as an indicator for diagnostic capability,
our results illustrate that the diagnostic performance of
these 3D neuroretinal rim parameters (ie, MDB thickness,
BMO-MRW, and rim volume) exceeds that of 2D RNFL
thickness in almost all quadrants and sectors (Table 2).
Also, Figures 4 and 5 illustrate a trend that sensitivity and
AUROC curve values for these 3D neuroretinal rim
parameters were superior to the 2D RNFL parameter. On
the basis of our results, the development of new 3D SD-
OCT parameters may augment or supplement the diag-
nostic capability of existing SD-OCT parameters, such as
2D RNFL thickness.
Multiple groups have acknowledged the advantages of
3D OCT imaging as well as the disadvantages of 2D RNFL
thickness measurements in glaucoma. For example, groups
TABLE 1. Demographics of the Primary Open-Angle Glaucoma
and Normal Study Populations
POAG Normal P
No. eyes 35 30
No. right eyes/left eyes 20/15 11/19
Sex (male/female) 18/17 13/17 0.515





Cup-to-disc ratio* 0.67±0.17 0.4±0.18 <0.0001
Visual fieldw
Mean deviation (dB) 8.15±7.35 1.78±1.88 <0.0001
Pattern SD (dB) 6.29±3.82 1.78±0.79 <0.0001
Race 35 30 0.811
White 4 3




All results are described in the format of mean±SD unless indicated
otherwise.
*Cup-to-disc ratio as performed through clinical assessment by trained
ophthalmologist.
wVisual field data obtained through Humphrey’s Visual Field testing.
z“Other” racial group represents a patient of unspecified European
descent.
POAG, primary open-angle glaucoma.
TABLE 2. Comparison of Diagnostic Capability of Retinal Nerve Fiber Layer and 5 Neuroretinal Rim Ocular Coherence Tomography
Parameters for Primary Open-Angle Glaucoma
2D RNFL Thickness 3D MDB Thickness 3D BMO-MRW 3D Rim Volume 2D Rim Area 2D Rim Thickness
AUROC (SE) AUROC (SE) AUROC (SE) AUROC (SE) AUROC (SE) AUROC (SE)
Global 0.850 (0.046) 0.884 (0.045) 0.928 (0.036) 0.892 (0.042) 0.837 (0.050) 0.884 (0.043)
Inferior 0.875 (0.043) 0.903 (0.042) 0.927 (0.036) 0.905 (0.040) 0.821 (0.051) 0.910 (0.039)
Superior 0.816 (0.052) 0.811 (0.056) 0.875 (0.042) 0.842 (0.050) 0.792 (0.058) 0.793 (0.056)
Nasal 0.721 (0.065) 0.831 (0.053) 0.867 (0.045) 0.835 (0.050) 0.815 (0.054) 0.795 (0.055)
Temporal 0.678 (0.067) 0.796 (0.054) 0.838 (0.049) 0.770 (0.058) 0.735 (0.061) 0.725 (0.063)
Superotemporal 0.818 (0.053) 0.790 (0.057) 0.877 (0.042) 0.830 (0.050) 0.783 (0.059) 0.799 (0.054)
Inferotemporal 0.869 (0.046) 0.885 (0.043) 0.946 (0.026) 0.917 (0.036) 0.818 (0.053) 0.911 (0.038)
Superonasal 0.760 (0.059) 0.823 (0.056) 0.870 (0.043) 0.819 (0.056) 0.783 (0.060) 0.776 (0.060)
Inferonasal 0.806 (0.055) 0.889 (0.044) 0.902 (0.041) 0.871 (0.046) 0.803 (0.053) 0.861 (0.047)
All results are described in the format of mean (SE) unless indicated otherwise.
AUROC indicates area under the receiver operating characteristic; 2D indicates 2-dimensional; 3D, 3-dimensional; BMO-MRW, Bruch’s membrane
opening -minimum rim width; MDB, minimum distance band; POAG, primary open-angle glaucoma; RNFL, retinal nerve fiber layer.
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have suggested that the 3D BMO-MRW not only may have
better diagnostic capability compared with 2D RNFL
thickness in humans (AUROC, 0.96 vs. 0.92, respec-
tively),19 but may also have better structure-function cor-
relation with visual field defects (P<0.01).25,28 Our group
has also shown that peripapillary retinal thickness param-
eters derived from 3D volume scans have excellent diag-
nostic capability with fewer algorithmic errors for detecting
glaucoma as compared with peripapillary RNFL thickness
(P=0.03).22 According to this22 and other papers, the
performance of many 3D imaging parameters are not as
affected by RNFL reflectivity loss, myopia, and PPA in
preliminary investigations.9,42 Unlike some 3D parameters,
the reliability of RNFL thickness as a diagnostic indicator
decreases in such scenarios, for example when there is PPA
or RNFL reflectivity loss due to advanced glaucoma, or
when measurements are made in nasal quadrants.6,8,9 In
addition, RNFL thickness is measured around a 3.4mm or
more diameter circle centered on the ONH.5,7,9,21 However,
the lack of a true anatomic landmark as the focal center for
circle scans allows for inaccuracies in RNFL measurements
due to decentration,19,21 which has been reported in even
27.8% of RNFL scans.43 It has been reported that for mild
to advanced glaucoma, 70% to 94% of RNFL defects are
diffuse in nature with some patients exhibiting changes only
nearer to the RPE/BM complex.18 As such, measuring at a
fixed distance from the disc can lead to misdiagnosis in
certain patients, because there are individual as well as
ethnic variations in disc size and because the RNFL is
normally thicker closer to the RPE/BM complex. Unlike
2D RNFL circle scans, 3D parameters (ie, MDB thickness
and rim volume) described in this study are derived from
2020-degree ONH volume raster scans that are capable
of gathering data from the entire retina surrounding the
ONH. These volume scans do not face the same limitations
as RNFL thickness and can be considered as the next step
for diagnostic imaging in glaucoma, because 3D volume
scans are not as affected by an artifact in a single frame
compared with a 2D scan which consists of just a single
frame or B-scan. Plus, the peripapillary 2D RNFL thick-
ness circle scan and the BMO-MRW radial scan are both
largely focused on imaging a singular anatomic tissue, that
is, the RNFL and the neuroretinal rim, respectively. In
contrast, a single 3D ONH volume scan can generate many
parameters, such as cup volume, MDB thickness and area,
rim volume, rim area, rim thickness, peripapillary retinal
thickness22 and volume, and peripapillary RNFL thickness
and volume. Therefore, the results of this study are in
agreement with past evidence that suggest that 3D SD-OCT
derived parameters and 3D volume scans are superior to
2D parameters and are not subject to the same limitations
of RNFL thickness measurements.
In comparing 3D neuroretinal rim parameters
derived from volume raster scans (MDB thickness, rim
volume) with those derived from radial scans (BMO-
MRW), our study did not show any significant differences
in diagnostic capability among 3D raster scan parameters
and 3D radial scan parameters (ie, false discovery rate P-
values >0.05). Although there are no large studies which
specifically compare BMO-MRW radial versus MDB
raster scan protocols for rim parameters, the inherent
differences in actual area scanned may temper the study
design and conclusions of any such a study. The BMO-
MRW radial scan is performed through radial cuts that
are corrected according to the Fovea-BMO center
(FoBMO) axis. The diagnostic utility of this feature has
yet to be established and are currently inconclusive. A
recent study by Mwanza et al44 has shown that adjust-
ments made according to the fovea-disc angle have no
consistent effect on diagnostic performance.26,45 However,
it has been demonstrated by He et al46 that the rotation of
the radial scans along the FoBMO axis results in a sig-
nificantly shifted alignment between BMO-MRW scans
and those not utilizing the FoBMO axis correction,
thereby resulting in pairwise comparisons between non-
identical quadrants and sectors. Future larger studies are
needed to better define the differences between the MDB
thickness parameter with associated 3D raster volume
scan and the BMO-MRW parameter with associated
radial scan protocol.
In terms of the image acquisition time and the result-
ing number of parameters procured, the 3D raster volume
scan may have several advantages over the BMO-MRW
radial scan protocol. For example, there are extra manual
steps involved in the BMO-MRW radial scan protocol that
may have contributed to its slightly improved, although not
statistically better, diagnostic capability compared with
raster scan parameters (ie, MDB thickness and rim
volume; Table 2). Before the BMO-MRW radial scan is
done, one ideally needs to obtain corneal curvature read-
ings from a keratometer and then input that corneal data
FIGURE 4. The diagnostic capabilities and area under the
receiver operating characteristic curves for gold standard 2-
dimensional (2D) retinal nerve fiber layer (RNFL) versus 3-
dimensional (3D) global neuroretinal rim parameters [Bruch’s
membrane opening-minimum rim width (BMO-MRW), mini-
mum distance band (MDB), rim volume].
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into the Heidelberg Spectralis imaging device. Then the
operator must determine the FoBMO axis. Then for this
study, manual correction of the BMO border during the
scan process was performed in the clinic for the 24 radial
BMO-MRW scans. In contrast, for the MDB raster scan
protocol, no individualized keratometry readings or man-
ual correction of the RPE/BM complex was done during
the scan process. Therefore, for this study, the BMO-MRW
measurements with keratometry readings and with BMO
manual corrections took up to 10 minutes per subject and
resulted in neuroretinal rim measurements, whereas the 3D
volume raster scan took <2 minutes and resulted in cup,
neuroretinal rim, RNFL, and peripapillary retinal param-
eters (ie, cup volume, MDB thickness and area, rim volume,
rim area, rim thickness, peripapillary retinal thickness22 and
volume, and peripapillary RNFL thickness and volume). It
should be noted that for the MDB and other raster scan-
derived parameters, poor-quality frames in the dataset were
manually identified and automatically corrected by inter-
polation from good data using the in-house algorithm.
Given the differing methods of image quality control, fur-
ther studies are needed comparing the diagnostic ability of
the BMO-MRW to the MDB thickness parameter, where
correction of segmentation data for both radial and raster
scan protocols is standardized and also comparable
between studies. For example, in contrast to a study by
Pollet-Villard et al,28 the MDB thickness in our study was
calculated without manual measurement of the neuroretinal
rim tissue thickness. The raster line scan protocol presented
also offers the advantage of having a higher density of
information in the periphery near the RPE/BM complex
and in the peripapillary region, as opposed to the radial
scan protocol which has the lowest density of information
in the peripapillary region and the highest density of
information in the cup center, where there is usually space
and no clinically useful data. As such, although 3D rim
parameters have similar diagnostic capability for glaucoma,
the 3D raster volume scan in particular may be an impor-
tant tool to augment the current standard of care in glau-
coma OCT imaging.
There were some limitations to our study. Our RNFL
AUROC curve values were lower than other comparison
studies (Table 2),9,36 and this may have been because our
population contained a higher percentage of early glaucoma
subjects (51%) compared with other studies. In addition,
another study needs to be done to see if acquiring the BMO-
MRW without manual correction of the BMO border in the
clinic and without keratometry readings yields similar diagnostic
capability as theMDB scan protocol which does not need either
manual adjustment of the RPE/BM complex in the clinic and
which does not need keratometry readings. The small sample
size of our study also necessitates larger studies evaluating these
new 3D glaucoma OCT parameters, but the current study does
generate new hypotheses for these future studies.
In conclusion, this study corroborates existing liter-
ature that 3D neuroretinal rim parameters which utilize
anatomic landmarks derived from SD-OCT imaging are
useful in enhancing the current standard of care in glaucoma
FIGURE 5. The diagnostic ability and area under the receiver operating characteristic curves for gold standard 2-dimensional (2D)
retinal nerve fiber layer thickness (RNFL) versus 3-dimensional (3D) neuroretinal rim parameters [Bruch’s membrane opening-minimum
rim width (BMO-MRW), minimum distance band (MDB), rim volume]. The 8 regions depicted include 4 quadrants (ie, inferior, superior,
nasal, and temporal) and 4 sectors (ie, superotemporal, inferotemporal, superonasal, and inferonasal).
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diagnostics. MDB thickness, rim volume, and BMO-MRW
are 3 such parameters that demonstrate superiority to 2D
RNFL circle scans, but show similar diagnostic capability
when compared with each other. Future studies are required
to expand upon our current knowledge of 3D parameters,
their individual advantages, and how best to utilize them
alongside other clinical markers for glaucoma.
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